Symptom practice guide for telephone assessment of patients with cancer treatment-related cardiotoxic dyspnea: Adaptation and evaluation of acceptability

Cardio-Oncology
F KellyD Stacey

Abstract

Patients with cancer treatment-related cardiotoxicity, which may manifest as heart failure (HF), can present with dyspnea. Nurses frequently assess, triage and offer self-care strategies to patients experiencing dyspnea in both the cardiology and oncology settings. However, there are no known tools available for nurses to manage patients in the setting of cancer treatment-related cardiotoxicity. The objective of this study was to adapt and evaluate the acceptability of an evidence-informed symptom practice guide (SPG) for use by nurses over the telephone for the assessment, triage, and management of patients experiencing dyspnea due to cancer treatment-related cardiotoxicity. The CAN-IMPLEMENT© methodology guided this descriptive study. A systematic search was conducted in four databases to identify cardio-oncology and HF guidelines and systematic reviews. Screening was conducted by two reviewers, with data extracted into a recommendation matrix from eligible guidelines and systematic reviews on: assessment criteria, medications, and/or self-care strategies to manage dyspnea. Healthcare professionals with an expertise in oncology and/or cardiology were recruited using purposeful and snowball sampling. Evaluation of acceptabilit...Continue Reading

References

Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine
Sep 19, 2002·Cancer·Deborah L Keefe
Jun 13, 2003·Journal of Advanced Nursing·Karen Cox, Eleanor Wilson
Aug 3, 2005·BMJ : British Medical Journal·UNKNOWN GESICA Investigators
Feb 17, 2007·BMC Medical Research Methodology·Beverley J SheaLex M Bouter
Mar 3, 2007·Progress in Cardiovascular Diseases·Klaus K Witte, Andrew L Clark
Jun 22, 2007·Emergency Medicine Journal : EMJ·Michele TwomeyJonathan E Myers
Jan 22, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·David H HenryDavid Cella
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Dec 1, 2009·Critical Care Clinics·Deepti BehlTimothy J Moynihan
Jun 2, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Melissa C BrouwersUNKNOWN AGREE Next Steps Consortium
Jul 7, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Melissa C BrouwersUNKNOWN AGREE Next Steps Consortium
Jul 24, 2010·Journal of the American College of Cardiology·Daniel FerranteUNKNOWN GESICA Investigators
Mar 10, 2012·Journal of Diabetes Science and Technology·Neda RatanawongsaDean Schillinger
Apr 25, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amanda Digel VandykDawn Stacey
Mar 12, 2013·Nursing Research and Practice·Dawn StaceyUNKNOWN The Pan-Canadian Oncology Symptom Triage and Remote Support Group (COSTaRS)
Dec 23, 2014·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Dawn StaceyUNKNOWN Pan-Canadian Oncology Symptom Triage and Remote Support COSTaRS Team
Jul 3, 2015·International Journal of Evidence-based Healthcare·Micah D J PetersCassia Baldini Soares
Dec 6, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianDaniel Lenihan
Dec 8, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Joseph J ChenKim-Lien Nguyen
Jan 22, 2017·Journal of Medical Internet Research·Nazli BashiDarren Walters
Apr 19, 2016·Cardio-Oncology·Sergio Barros-GomesHector R Villarraga

❮ Previous
Next ❯

Software Mentioned

Excel©
cardiac
RN
COSTaRS
AMSTAR
CAN
COSTaRS SPG
IMPLEMENT©

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.